DIVITA CHARLES III

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
DIVITA CHARLES III's trades of Teladoc Health Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-03 2026-06-02 S Sale
46,674 -3.6%
452.39
US$2,574,013
46,674 -3.6% 452.39 US$2,574,013
2026-06-02 2026-06-02 PrS Proposed sale
77,925
462.82
US$944,490
77,925 462.82 US$944,490
2026-03-12 2026-03-11 S Sale
14,848 -9.7%
139.52
US$3,038,500
14,848 -9.7% 139.52 US$3,038,500
2026-03-12 2026-03-11 S Sale
27,731 -7.1%
5.49
US$152,243
27,731 -7.1% 5.49 US$152,243
2026-03-11 2026-03-11 PrS Proposed sale
27,731
5.49
US$152,252
27,731 5.49 US$152,252
2026-03-03 2026-03-02 S Sale
50,145 -13.3%
5.12
US$256,592
50,145 -13.3% 5.12 US$256,592
2026-03-02 2026-03-02 PrS Proposed sale
50,145
5.12
US$256,577
50,145 5.12 US$256,577
2025-12-11 2025-12-11 PrS Proposed sale
17,138
7.63
US$130,837
17,138 7.63 US$130,837
2025-12-11 2025-12-11 S Sale
17,138 -7.9%
7.63
US$130,837
17,138 -7.9% 7.63 US$130,837
2025-09-11 2025-09-11 PrS Proposed sale
16,787
7.59
US$127,435
16,787 7.59 US$127,435
2025-09-11 2025-09-11 S Sale
16,787 -8.6%
7.59
US$127,435
16,787 -8.6% 7.59 US$127,435